Treatment of chronic hepatitis C - Combination therapy permanently eradicates the virus in at least 40% of patients

被引：19

作者：

Davis, GL ^{[1
]}

机构：

[1] Univ Florida, Coll Med, Dept Med, JHM Hlth Ctr,Sect Hepatobiliary Dis, Gainesville, FL 32610 USA

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2001年 / 323卷 / 7322期

关键词：

D O I：

10.1136/bmj.323.7322.1141

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1141 / 1142

页数：2

共 13 条

[1]

Davis GL, 1998, HEPATOLOGY, V28, p390A

[2] Current therapy for chronic hepatitis C [J].

Davis, GL .

GASTROENTEROLOGY, 2000, 118 (02) :S104-S114

[3] Pegylated (40 kDa) interferon alfa-2a (PEGASYS®) in combination with ribavirin:: Efficacy and safety results from a phase III, randomized, actively-controlled, multicenter study [J].

Fried, MW ;

Shiffman, ML ;

Reddy, RK ;

Smith, C ;

Marino, G ;

Goncales, F ;

Haeussinger, D ;

Diago, M ;

Carosi, G ;

Zarski, JP ;

Hoffman, J ;

Yu, J .

GASTROENTEROLOGY, 2001, 120 (05) :A55-A55

[4]

KJAERGARD II, 2001, BRIT MED J, V323, P1151

[5] A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C [J].

Lindsay, KL ;

Trepo, C ;

Heintges, T ;

Shiffman, ML ;

Gordon, SC ;

Hoefs, JC ;

Schiff, ER ;

Goodman, ZD ;

Laughlin, M ;

Yao, RJ ;

Albrecht, JK .

HEPATOLOGY, 2001, 34 (02) :395-403

[6]

Manns MP, 2000, HEPATOLOGY, V32, p297A

[7]

MARCELLIN P, 1994, LIVER, V14, P302

[8] Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C [J].

McHutchison, JG ;

Gordon, SC ;

Schiff, ER ;

Shiffman, ML ;

Lee, WM ;

Rustgi, VK ;

Goodman, ZD ;

Ling, MH ;

Cort, S ;

Albrecht, JK .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (21) :1485-1492

[9] Impact of interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C [J].

Poynard, T ;

McHutchison, J ;

Davis, GL ;

Esteban-Mur, R ;

Goodman, Z ;

Bedossa, P ;

Albrecht, J .

HEPATOLOGY, 2000, 32 (05) :1131-1137

[10]

Poynard T, 1996, HEPATOLOGY, V24, P778

← 1 2 →